About New Element Medicine
New Element Medicine is a company based in Zhenjiang (China) founded in 2012 by Shi Dongfang.. New Element Medicine has raised $152.05 million across 5 funding rounds from investors including Livzon Pharmaceutical, Kaitai Capital and Fortune Capital Partners. New Element Medicine offers products and services including ABP-671 and ABP-745. New Element Medicine operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, NGM Biopharmaceuticals, Erasca and Revolution Medicines, among others.
- Headquarter Zhenjiang, China
- Founders Shi Dongfang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Atom Therapeutics Co. Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$152.05 M (USD)
in 5 rounds
-
Latest Funding Round
$83 M (USD), Series D
Oct 16, 2023
-
Investors
Livzon Pharmaceutical
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of New Element Medicine
New Element Medicine offers a comprehensive portfolio of products and services, including ABP-671 and ABP-745. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats chronic gout and hyperuricemia through clinical trials.
Addresses acute gout with safety and efficacy in trials.
Funding Insights of New Element Medicine
New Element Medicine has successfully raised a total of $152.05M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $83 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series D — $83.0M
- First Round First Round
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Series D - New Element Medicine | Valuation | Kaitai Capital Management | |
| Jan, 2022 | Amount | Series C - New Element Medicine | Valuation | ShenZhen GTJA Investment Group | |
| Jan, 2020 | Amount | Series B - New Element Medicine | Valuation | Kaitai Capital Management , Livzon Pharmaceutical |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in New Element Medicine
New Element Medicine has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Livzon Pharmaceutical, Kaitai Capital and Fortune Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Kaitai Capital is engaged in innovation investment management services.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by New Element Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - New Element Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
New Element Medicine Comparisons
Competitors of New Element Medicine
New Element Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, NGM Biopharmaceuticals, Erasca and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on New Element Medicine
Frequently Asked Questions about New Element Medicine
When was New Element Medicine founded?
New Element Medicine was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Where is New Element Medicine located?
New Element Medicine is headquartered in Zhenjiang, China. It is registered at Zhenjiang, Jiangsu, China.
Who is the current CEO of New Element Medicine?
Shi Dongfang is the current CEO of New Element Medicine. They have also founded this company.
Is New Element Medicine a funded company?
New Element Medicine is a funded company, having raised a total of $152.05M across 5 funding rounds to date. The company's 1st funding round was a Series B of $21.85M, raised on Jun 01, 2017.
What does New Element Medicine do?
Founded in 2012 and based in Zhenjiang, China, the company operates in the biotechnology sector. Focus is placed on developing pharmaceutical products for cancer and metabolic conditions. Pipeline includes URAT-1 targeting gout and hyperuricemia, as well as ABP-6061 and ABP-431 for non-alcoholic steatohepatitis, gastric cancer, colon cancer, and breast cancer. Operations center on research and drug development.
Who are the top competitors of New Element Medicine?
New Element Medicine's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does New Element Medicine offer?
New Element Medicine offers ABP-671 and ABP-745.
Who are New Element Medicine's investors?
New Element Medicine has 13 investors. Key investors include Livzon Pharmaceutical, Kaitai Capital, Fortune Capital Partners, Huajin Securities, and NNFE.